Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA

Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible. Here, we demonstrate that for one patient, with the first rep...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Martignetti, John A, Camacho-Vanegas, Olga, Priedigkeit, Nolan, Camacho, Catalina, Pereira, Elena, Lin, Li, Garnar-Wortzel, Leopold, Miller, Dagny, Losic, Bojan, Shah, Hardik, Liao, Jun, Ma, Jian, Lahiri, Pratik, Chee, Mark, Schadt, Eric, Dottino, Peter
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press Inc. 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3924545/
https://ncbi.nlm.nih.gov/pubmed/24563622
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares